Haberman Associates

Haberman Associates is a Boston-based consulting firm that specializes in science and technology strategy for biotechnology, pharmaceutical, and other life science companies. Founded in 1993, our firm has been helping clients worldwide, with a focus on North America, Europe, and Japan, increase the effectiveness of their drug and diagnostic discovery and development, commercialization of new research products, assessment of new business opportunities, and partnering. Our team of experts consults, writes, and speaks on critical issues that determine the success of life science companies.

Type of Clients We Help

Our clients range from industry start-ups to major corporations, including:

• Pharmaceutical companies
• Biotechnology companies
• Diagnostics companies
• Research products companies

We work with clients from different life science sectors to help them discover and develop new drugs, diagnostics, and research products, improve their drug pipelines, identify and evaluate potential partners, develop new applications for their technologies, and penetrate new markets. Our clients benefit from our extensive experience in the industry, without the training and overhead burdens associated with large, relatively junior staffs.

Type of Engagements

Our typical consulting engagements have included:

• Strategic new product and R&D planning
• Opportunity assessment and assistance in partnering
• Technology assessment
• Assessment of pipeline drugs and assistance in go/no go decisions
• Proprietary strategic reports on areas for potential business expansion
• Due diligence on potential partners and investment or acquisition candidates

We offer flexible engagement options tailored to our clients' specific needs, and we are committed to delivering high-quality results that help our clients achieve their goals.

Who We Are

Our team is led by Allan B. Haberman, Ph. D., a renowned expert in the biotechnology and pharmaceutical industries. Dr. Haberman has authored several book-length reports and articles on critical issues affecting the life science industry, including cancer immunotherapy, gene therapy, and protein-protein interaction modulators. Our team also includes experienced consultants with diverse backgrounds and expertise in various areas of the life science industry.

The Biopharmaceutical Consortium

We partner with the Biopharmaceutical Consortium, a group of independent consultants with complementary skills and expertise. The Consortium combines the advantages of large and small consulting firms, providing clients with expansive depth and breadth of experience without the training and overhead burdens associated with large, relatively junior staffs.

Publications

Our book-length reports have been published by leading organizations such as Decision Resources, Cambridge Healthtech Institute, and Informa Healthcare. Our articles have appeared in leading publications such as Genetic Engineering & Biotechnology News, Pharma DD, and PharmaWeek, providing in-depth research and analysis in several key areas of the biotech and pharmaceutical industries. Both our reports and articles are designed to help you understand and maximize opportunities in the ever-changing science, technology, market, and strategic issues that affect the life science industry.